Lexicon Pharmaceuticals Stock Price. Everything You Need To Know About The Lexicon Pharmaceuticals Stock!
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company is headquartered in The Woodlands, Texas and currently employs 135 full-time employees. The company went IPO on 2000-04-07. The firm is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and LX2761. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The firm is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. Its LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of SGLT2 in the kidney.
Lexicon Pharmaceuticals Stock Price. Everything You Need To Know About The Lexicon Pharmaceuticals Stock! performance -
Employees
135 -
Company HQ
The Woodlands -
Website
https://www.lexpharma.com/ -
LXRX Asset Type
Common Stock -
LXRX Market Capitalization
487.5M - Earnings Per Share -0.8
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.634
Employees
135Company HQ
The WoodlandsWebsite
https://www.lexpharma.com/LXRX Asset Type
Common StockLXRX Market Capitalization
487.5MAre you a retail investor from Malaysia, Thailand, Indonesia or Vietnam looking to expand your investment portfolio? Consider investing in Lexicon Pharmaceuticals, a leading biopharmaceutical company specializing in the discovery and development of innovative treatments for various diseases. With a diverse pipeline of potential therapies, Lexicon has a strong track record of success and a promising future. But how can you invest in Lexicon Pharmaceuticals from your home country? Zorion, the investment platform designed specifically for retail investors in Malaysia, Thailand, Indonesia and Vietnam, offers easy access to real US stocks like Lexicon Pharmaceuticals. With investment insights, recommendations, and educational resources at your disposal, Zorion empowers you to make informed investment decisions. Start investing in Lexicon Pharmaceuticals today and maximize your potential for profitable returns.